Pendal Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$900K Sell
11,578
-4,660
-29% -$378K 0.01% 309
2022
Q3
$1.31M Sell
16,238
-321
-2% -$28.8K 0.01% 241
2022
Q2
$1.49M Sell
16,559
-19,201
-54% -$1.95M 0.01% 239
2022
Q1
$3.97M Sell
35,760
-26
-0.1% -$2.75K 0.03% 165
2021
Q4
$3.7M Buy
35,786
+24,896
+229% +$2.88M 0.03% 175
2021
Q3
$1.36M Buy
10,890
+2,675
+33% +$346K 0.01% 279
2021
Q2
$1.02M Sell
8,215
-3,596
-30% -$452K 0.01% 337
2021
Q1
$1.4M Sell
11,811
-4,185,490
-100% -$491M 0.01% 270
2020
Q4
$492M Sell
4,197,301
-265,249
-6% -$29.2M 5.14% 3
2020
Q3
$464M Buy
4,462,550
+608,486
+16% +$61.1M 5.67% 5
2020
Q2
$353M Sell
3,854,064
-18,627
-0.5% -$1.79M 4.82% 6
2020
Q1
$349M Sell
3,872,691
-68,522
-2% -$7.29M 5.96% 5
2019
Q4
$447M Sell
3,941,213
-84,489
-2% -$9.27M 5.86% 3
2019
Q3
$437M Buy
4,025,702
+53,831
+1% +$5.62M 5.69% 2
2019
Q2
$374M Buy
3,971,871
+3,877,702
+4,118% +$354M 5.21% 3
2019
Q1
$7.67M Sell
94,169
-3,287,540
-97% -$294M 0.11% 107
2018
Q4
$296M Buy
3,381,709
+204,066
+6% +$19.1M 4.72% 2
2018
Q3
$313M Buy
3,177,643
+3,166,362
+28,068% +$293M 4.24% 6
2018
Q2
$966K Sell
11,281
-1,539
-12% -$129K 0.01% 302
2018
Q1
$1.03M Buy
12,820
+962
+8% +$79.3K 0.01% 321
2017
Q4
$958K Buy
11,858
+835
+8% +$66.9K 0.01% 307
2017
Q3
$857K Buy
11,023
+571
+5% +$47.4K 0.01% 328
2017
Q2
$928K Buy
+10,452
New +$881K 0.01% 298

Other funds holding MDT

Pendal Group's MDT Position: Q4 2022 in Review

Pendal Group reduced its Medtronic (MDT) stake by 29% in Q4 2022, selling an estimated $378K and leaving 11,578 shares worth $900K. The position accounts for 0.01% of the portfolio, ranked #309.

Pendal Group first reported a position in MDT in Q2 2017 and has held it in 23 quarters since. The position peaked at $492M in Q4 2020. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Pendal Group held 11,578 shares of Medtronic worth $900K as of Q4 2022.
  • Pendal Group sold 4,660 Medtronic shares in Q4 2022, an estimated $378K.
  • Medtronic made up 0.01% of Pendal Group's portfolio in Q4 2022, its #309 holding.
  • Pendal Group first reported a position in Medtronic in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Medtronic position peaked at $492M in Q4 2020.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.